Clinical trial for Urothelial Carcinoma
Official title Urothelial Cancer Screening in Individuals With Lynch Syndrome Using a Urine Tumor DNA Panel (LS-URO Study)
ClinicalTrials.gov ID: NCT06218433
What this study is testing
- What it's testing
- The study aims to see if a urine tumor DNA panel can detect early urothelial cancers in individuals with Lynch syndrome.
- Who it's for
- Adults who have Lynch syndrome and do not currently have symptoms of urothelial cancer.
- What's involved
- Participants will provide urine samples that are analyzed for tumor DNA, and may have additional follow‑up tests if the results suggest cancer.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 50 to 75. Healthy volunteers may be eligible.
You may be able to join if
- Willing and able to provide informed consent
- Diagnosis of Lynch syndrome
- Age 50 - 75 years at study recruitment
You likely can't join if
- Concurrent urothelial carcinoma
The study team makes the final eligibility decision.
Where it is enrolling
- Vancouver, Canada
- Tampere, Finland
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part, but confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 50 years to 75 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
This study is enrolling now at Vancouver, Canada; Tampere, Finland. Enter your location above to see the nearest enrolling site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool that is independent of the study sponsor. Details come from ClinicalTrials.gov. The study team decides eligibility, and your own doctor gives medical advice.